Hosted on MSN9h
Drugs approved for other diseases may unlock a faster path to Alzheimer’s treatment, UNLV researcher says
Doctor Jeffrey Cummings is world-renowned in the field of Alzheimer's research and he leads UNLV's Center for Transformative ...
Science Daily10h
Novel method to synthesize valuable fluorinated drug compounds
Researchers have pioneered a new catalytic transformation that converts epoxides into fluorinated oxetanes, a coveted but difficult-to-make class of drug molecules that escaped synthetic preparation ...
Combining protein therapy and focused ultrasound therapy can improve cancer treatment
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...
Synthesis method unlocks a pathway to valuable fluorinated drug compounds for new medicines
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
Combined organ-specific mRNA and lipid nanoparticle therapy could repair damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
Rolling Out19h
5 facts about lemon balm’s potential for weight loss
Discover what science reveals about lemon balm's effectiveness for weight management, its benefits, and risks as experts weigh in on this trending herb.
Fort Carson's new fitness center named after WWI Medal of Honor Recipient
Today a new fitness center will be opening on Fort Carson. It will be 66 thousand square feet with an indoor running track, ...
Neurology Advisor21h
FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy
The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).